153 related articles for article (PubMed ID: 37047012)
21. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH
Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924
[TBL] [Abstract][Full Text] [Related]
22. Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation.
Choi HS; Kim MK; Choi YK; Shin YC; Cho SG; Ko SG
BMC Complement Altern Med; 2016 Apr; 16():122. PubMed ID: 27121110
[TBL] [Abstract][Full Text] [Related]
23. Butein Activates Autophagy Through AMPK/TSC2/ULK1/mTOR Pathway to Inhibit IL-6 Expression in IL-1β Stimulated Human Chondrocytes.
Ansari MY; Ahmad N; Haqqi TM
Cell Physiol Biochem; 2018; 49(3):932-946. PubMed ID: 30184535
[TBL] [Abstract][Full Text] [Related]
24. Molecular chemotherapeutic potential of butein: A concise review.
Jayasooriya RGPT; Molagoda IMN; Park C; Jeong JW; Choi YH; Moon DO; Kim MO; Kim GY
Food Chem Toxicol; 2018 Feb; 112():1-10. PubMed ID: 29258953
[TBL] [Abstract][Full Text] [Related]
25. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract][Full Text] [Related]
26. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501
[TBL] [Abstract][Full Text] [Related]
27. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
[TBL] [Abstract][Full Text] [Related]
29. Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8.
Rasheed Z; Akhtar N; Khan A; Khan KA; Haqqi TM
J Pharmacol Exp Ther; 2010 May; 333(2):354-63. PubMed ID: 20164300
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
[TBL] [Abstract][Full Text] [Related]
31. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
Moon DO; Kim MO; Choi YH; Kim GY
Mol Cancer Ther; 2010 Jun; 9(6):1583-95. PubMed ID: 20515942
[TBL] [Abstract][Full Text] [Related]
32. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
Bai X; Ma Y; Zhang G
Oncol Rep; 2015 Jun; 33(6):3085-92. PubMed ID: 25962638
[TBL] [Abstract][Full Text] [Related]
33. Syringic acid regulates suppression of the STAT3/JNK/AKT pathway via inhibition of human ovarian teratoma cancer cell (PA-1) growth-in vitro study.
Yang L; Qu C; Jin J; Yang H; Pei L
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-9. PubMed ID: 33759321
[TBL] [Abstract][Full Text] [Related]
34. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
Guo YQ; Lu P; Duan ZF; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
[TBL] [Abstract][Full Text] [Related]
35. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway.
Kim B; Kim HS; Kim S; Haegeman G; Tsang BK; Dhanasekaran DN; Song YS
Cancer Res Treat; 2017 Apr; 49(2):338-349. PubMed ID: 27456942
[TBL] [Abstract][Full Text] [Related]
36. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
37. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Zhao X; Guo X; Shen J; Hua D
Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
[TBL] [Abstract][Full Text] [Related]
38. Butein induces intrinsic pathway of apoptosis, vimentin proteolysis, and inhibition of cancer stem cell population in a human papillary thyroid cancer cell line.
Tripathi D; Kulkarni S
Toxicol In Vitro; 2021 Dec; 77():105244. PubMed ID: 34481015
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibition of human ovarian cancer cells by blocking STAT3 activation with small interfering RNA.
Cai L; Zhang G; Tong X; You Q; An Y; Wang Y; Guo L; Wang T; Zhu D; Zheng J
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):73-80. PubMed ID: 19880237
[TBL] [Abstract][Full Text] [Related]
40. Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways.
Ma CY; Ji WT; Chueh FS; Yang JS; Chen PY; Yu CC; Chung JG
J Agric Food Chem; 2011 Aug; 59(16):9032-8. PubMed ID: 21770460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
